Cargando…
MRI-Based Quantitation of Hepatic Steatosis Does Not Predict Hypertrophy Rate after Portal Vein Embolization in Patients with Colorectal Liver Metastasis and Normal to Moderately Elevated Fat Fraction
The aim of this study was to correlate the pre-procedural magnetic-resonance-imaging-based hepatic fat fraction (hFF) with the degree of hypertrophy after portal vein embolization (PVE) in patients with colorectal cancer liver metastases (CRCLM). Between 2011 November and 2020 February, 68 patients...
Autores principales: | Hitpass, Lea, Amygdalos, Iakovos, Sieben, Paul, Raaff, Vanessa, Lang, Sven, Bruners, Philipp, Kuhl, Christiane K., Barabasch, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125629/ https://www.ncbi.nlm.nih.gov/pubmed/34067008 http://dx.doi.org/10.3390/jcm10092003 |
Ejemplares similares
-
Primary Tumor Location Is a Prognostic Factor for Intrahepatic Progression-Free Survival in Patients with Colorectal Liver Metastases Undergoing Portal Vein Embolization as Preparation for Major Hepatic Surgery
por: Hitpass, Lea, et al.
Publicado: (2020) -
Signal changes in T2-weighted MRI of liver metastases under bevacizumab—A practical imaging biomarker?
por: Thüring, Johannes, et al.
Publicado: (2020) -
Recurrent Colorectal Liver Metastases in the Liver Remnant After Major Liver Surgery—IRE as a Salvage Local Treatment When Resection and Thermal Ablation are Unsuitable
por: Hitpass, Lea, et al.
Publicado: (2021) -
Portal vein embolization with absolute ethanol to induce hypertrophy of the future liver remnant
por: Santhakumar, Cositha, et al.
Publicado: (2022) -
Influence of cholestasis on portal vein embolization-induced hypertrophy of the future liver remnant
por: Chang, Xinwei, et al.
Publicado: (2023)